期刊文献+

鼻咽癌三维调强治疗中腮腺受照射剂量分析 被引量:3

Analysis on radiation doses of the parotid during intensity-modulated radiation therapy for nasopharyngeal carcinoma
原文传递
导出
摘要 目的探讨鼻咽癌(NPC)三维调强放疗(IMRT)中腮腺的受照射剂量。方法 IMRT放疗的NPC患者49例,通过剂量体积直方图(DVH)计算鼻咽原发灶(GTV1)、阳性颈淋巴结区(GTV2)的照射剂量、两侧腮腺接受一定剂量照射的体积(V25)以及两侧腮腺一定体积所受的照射剂量。结果 GTV1照射剂量(70.81±1.79)Gy,GTV2(65.84±1.94)Gy。腮腺V25照射剂量:左侧(93.78±5.96)%,右侧(93.60±13.46)%。腮腺50%体积所受的照射剂量:左侧(36.72±3.29)Gy,右侧(37.53±3.21)Gy。临床口干症状:1级5例,2级31例,3级13例。结论 NPB IMRT中腮腺的受照射剂量比常规放疗低;唾液腺得到较常规放射治疗很好的保护,但仍然不能解决口干的放射性损伤问题。 Objective:To analyze the radiation doses of the parotid during intensity-modulated radiation therapy(IMRT) for nasopharyngeal carcinoma(NPC).Methods:With dose-volume histograms(DVH) of 49 patients with NPC treated by IMRT,radiation doaes were calculated for primary lesion(GTV1) and positive cervical lymph nodes(GTV2).The volumes of bilateral parotid glands receiving irradiation of certain dose(V25) and irradiated doses in certain volume of parotid glands were calculated as well.Results:Doses of GTV1 and GTV2 were(70.81±1.79) Gy and(65.84±1.94) Gy,respectively.V25 of left and right parotid were(93.78±5.96)% and(93.6±13.46)%,respectively.Doses delivered to 50% volume of left and right parotid were(36.72±3.29) Gy and(37.53±3.21) Gy,respectively.Clinical xerostomia occurred in 5 patients with grade Ⅰ,31 cases with grade Ⅱ and 13 cases with grade Ⅲ.Conclusion:Lower doses are delivered to the parotid during IMRT and salivary gland is protected better compared with conventional radiation therapy,but radiation damage of xerostomia can not be avoided.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第24期2901-2902,共2页 Jiangsu Medical Journal
关键词 鼻咽癌 调强放疗 Nasopharyngeal carcinoma Intensity-modulated radiation therapy
  • 相关文献

参考文献9

  • 1何侠,翟振宇,纪红,张宜勤.初治鼻咽癌调强适形放疗近期临床观察[J].肿瘤防治研究,2006,33(4):272-274. 被引量:31
  • 2Nishioka T, Shirato H, Arimoto T, et al. Reduction of radia- tion-induced xerostomia in nasopharyngeal carcinoma using CT simulation with laser patient marking and three-field irradiation technique[J]. Int J Radiat Oncol Biol Plays, 1997,38 (4), 705- 712.
  • 3American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia, New York: Lippincott-Raven [M].1997:33-38.
  • 4Teo P, Yu P, Lee WY, et al. Significant prognosticators alter primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography[J]. Int J Radiat Oncol Biol Phys, 1996,36(2) : 291-304.
  • 5Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma~ a pro- spective study on disease control and preservation of salivary funetion[J]. Cancer, 2004,101(7) : 1584-1593.
  • 6Lee N,Xia-P,Quivey JM,et al. Intensity-modulated radiother- apy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience[J]. Int J Radiat Oncol Biol Phys, 2002, 53(1) : 12-22.
  • 7Lu TX,Mai WY,Teh BS,et al. Initial experience using inten- sity-modulated radiotherapy for recurrent nasopharyngeal car- cinoma[J]. Int J Radiat Oncol Biol Phys, 2004,58 (3) : 682-687.
  • 8Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer[J]. World J Surg, 2003,27(7) : 832-837.
  • 9乐文友,戴建荣,高黎.鼻咽癌调强放疗等效均匀剂量优化方法对腮腺的保护作用[J].中华放射肿瘤学杂志,2006,15(6):484-488. 被引量:31

二级参考文献22

  • 1马金利,蒋国梁.调强适形放射治疗计划的优化目标与临床评价[J].中华放射肿瘤学杂志,2004,13(3):204-207. 被引量:14
  • 2Marc W. Munter, et al. Evaluation Of Salivary Gland Function After Treatment Of Head-And-Neck Tumors With Intensity-Modulated Radiotherapy By Quantitative Pertechnetate Scintigraphy[J]. Int J Radiation Oncology Biol Phys, 2004, 58(1): 175-184.
  • 3Ching-Yeh Hsiung, et al. Attenuation of Radiation Dose by the Skull Base Bone in Patients with Nasopharyngeal Carcinoma: Clinical Importance[J]. Radiology, 200l, 218: 457-463.
  • 4Michael K. M. Kam, et al. Intensity-Modulated Radiotherapy In Nasopharyngeal Carcinoma: Dosimetric Advantage Over Conventional Plans And Feasibility Of Dose Escalation[J]. Int J Radiation Ontology Biol Phys, 2003, 56( 1 ): 145-157.
  • 5Marc W, Munter, et al. Evaluation Of Salivary Gland Function After Treatment Of Head-And-Neck Tumors With Intensity-Modulated Radiotherapy By Quantitative Pertechnetate Scintigraphy[J]. Int J Radiation Ontology Biol Phys, 2004,58(1): 175-184.
  • 6Bin Steh, Shiao Ywoo, E Brian Bueler. Intensitymodulated radiation therapy(IMRT):a new promising technology in radiationeology[J]. The Oneologist, 1999,4:433-442.
  • 7Emarni B, Lyrnan J, Brown A, et al. Tolerance of normal tissue to the rapeutieir radiation[J]. Int J Radit Oneol Biol Phys,1991,21:109-122.
  • 8Olivier C,Emma T.Esophagus sparing with in lung tmor irradiation:an EUD-based optimization technique.Int J Radiation Oncology Biol Phys,2005,63:179-187.
  • 9Emma T,Olivier C,Marc LK.Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatement of intrahepatic tumors.Int J Radiat Oncol Biol Phys,2005,62:571-578.
  • 10Niemierko A.Reporting and analyzing dose distribution:a concept of equivalent uniform dose.Med Phys,1997,24:103-110.

共引文献60

同被引文献21

  • 1乐文友,戴建荣,高黎.鼻咽癌调强放疗等效均匀剂量优化方法对腮腺的保护作用[J].中华放射肿瘤学杂志,2006,15(6):484-488. 被引量:31
  • 2王翰章.中华口腔科学[M].北京:人民卫生出版社,2000.1127-9.
  • 3姚刚,王瑞.鼻咽癌的调强放射治疗探讨[J].现代医学影像学杂志,2008,17(3):159-160.
  • 4放射治疗肿瘤学组织.放射治疗肿瘤学组织网址.
  • 5Eibruch A, Ten -Ilaken,R.K.Kim,等.头颈部癌症在适形和调强放疗下剂量-体积对腮腺唾液腺功能的影响[J].中华放射肿瘤生物物理学杂志,1999,45:577-587.
  • 6Cooper J.S.Fu K,J 马克,等.头颈部肿瘤放射治疗的后期影响[J].中华放射肿瘤生物物理学杂志,1995,31:1141-1164.
  • 7M.D 莱斯利,Dische S.F.头颈部癌症在放射治疗期间和之后涎腺功能的早期变化[J].放射肿瘤学杂志,1994,30:26-32.
  • 8J 马克,C.C 戴维斯,V.L格茨曼,等.放射对腮腺唾液腺的功能影响的影响[J].中华放射肿瘤生物物理学杂志,1981,7:1013-1019.
  • 9Eisbrueh,T 耐登,CR布拉德福特,等.客观的评价穿刺后并进行放化结合治疗的头颈部癌症的作用[J].中华放射肿瘤生物物理学杂志,2002,53:23-28.
  • 10O.约瑟,维塔利,劳伦斯,等.放疗剂量-体积对涎腺功能的影响[J].中华放射肿瘤生物物理学杂志,2010,76:S59-S63.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部